This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This article focuses on how medical practices are valued by private equity-backed groups, and to an extent, health systems and other strategic acquirers. By: FOCUS InvestmentBanking Please see full Article below for more information.
Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. By: FOCUS InvestmentBanking But that’s been changing over the past few years and is likely to continue to grow moving forward.
Based on the large number of medical practices acquired over the past decade, you may think selling your practice is a routine process. By: FOCUS InvestmentBanking
In the pursuit of attractive equity returns, private equity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of private equity-backed roll-up activity.
They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. ” “We enjoyed working with the physician-owners at Mid-Michigan ENT, and are thrilled with this outcome,” said Eric Yetter, Managing Director and Healthcare Team Leader at FOCUS InvestmentBanking.
Serving a variety of end markets, including aerospace & defense, electronics and industrials, National offers especially deep experience in the medical end market across various implantable devices, including pacemakers, neuromodulation devices, defibrillators, batteries and capacitors. National”). appeared first on FOCUS.
Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets. FOCUS represented CORE in this transaction. appeared first on FOCUS.
Washington, DC, (September 27, 2024) – FOCUS InvestmentBanking (“FOCUS”), a national middle market investmentbanking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Dulles Eye Associates has joined ReFocus Eye Health as a supported practice.
Washington, DC, (August 15, 2023) – FOCUS InvestmentBanking (“FOCUS”), a national middle market investmentbanking firm providing merger, acquisition, divestiture and corporate finance services, announced today that it has added two new managing directors, Mike McCraw and William R. Bill”) Snow.
They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. “We We enjoyed working with Eric Yetter and Andy Snyder at FOCUS InvestmentBanking, said Richard Strabbing, M.D., who serves as Michigan ENT’s managing partner.
CORE, a private equity firm focused on manufacturing, industrial technology, and industrial services, previously acquired GEM, a provider of precision deep-drawn metal components and mechanical assemblies, in February 2023. PMP”), a provider of specialty stamping and machining services. FOCUS represented CORE in this transaction.
When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? They do not invest in risky biotech startups attempting to cure cancer (at least not within their traditional PE portfolios). Why do PE firms operate there?
Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. Despite the recent rash of M&A deals, the orthopedic business, like other medical fields, remains highly fragmented.
This article focuses on how medical practices are valued by private equity-backed groups, and to an extent, health systems and other strategic acquirers. Physician practices are almost always valued on a multiple of EBITDA basis in transactions with private equity groups or similar buyers. We explore each in turn below.
Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—private equity firms have a lot of capital to put to work. ENT and allergy is relatively new to private equityinvestment, with approximately ten major platforms currently operating.
The 6th annual Midwest M&A/Private Equity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.
PreK-12 Transactions PreK-12 Transaction Spotlight: Tyton Partners represented School Specialty in its Divestiture of EPS School Specialty , a PreK-12 supplemental curriculum provider, to Excolere Equity Partners. ISP Schools is a portfolio company of OMERS Private Equity.
Top 20 angel investor networks Growth Business guide to angel investor networks Angel network Regions Investment size Sectors No. Top 20 angel investor networks Growth Business guide to angel investor networks Angel network Regions Investment size Sectors No. Seventy per cent of clients raise some or all of the money sought.
On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 While the biggest recent deal, OneOncology is hardly the first oncology platform to be sold to a private equity group. Tahoe still owns a minority interest.
Based on the large number of medical practices acquired over the past decade, you may think selling your practice is a routine process. Most physician practices have a rollover equity component, meaning that sellers receive an equity interest in the buyer organization as part of their transaction value.
For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.
Summary Private equity-backed Physician Practice Management (“PPM”) companies in the ENT & Allergy space continued a conservative growth trajectory during Q1 2024. Introduction Private equity groups began investing in the ear, nose, and throat and allergy space in 2018.
Periculum Capital Company, LLC is pleased to announce it has advised Micro-Dyn Medical Systems, Inc., based private equity investor that specializes in acquiring software businesses in partnership with top mid-career executives. a leading health care software company, in its acquisition by The Brydon Group.
An applicant's medical history, lifestyle (like smoking habits), and family health history determine their life expectancy and risk. If you're interested in breaking into finance, check out our , Private Equity Course and , InvestmentBanking Course , which help thousands of candidates land top jobs every year.
If you're interested in breaking into finance, check out our , Private Equity Course and , InvestmentBanking Course , which help thousands of candidates land top jobs every year. Example: Medications for rare diseases, where research costs are high and patient populations are small, can often command high prices.
Non-Traditional Players’ Entry : Tech giants and private equity firms are increasingly investing in the healthcare software and IT sector, potentially leading to a surge in M&A activities. Billion): Private equity firm Thoma Bravo acquired NextGen Healthcare for an enterprise value of $1.8 Solganick & Co.
Summary Private equity’sinvestments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once private equity groups and lenders become comfortable with the interest rate environment. We expect continued transaction volume, though with a smaller average deal size.
As opposed to merely focusing on the market capitalization, which only accounts for the company’s equity value, the Enterprise Value Calculator considers the company’s debt, cash, and other financial liabilities. The aim is to offer patients a wider range of medical services and increase operational efficiency.
If you're interested in breaking into finance, check out our , Private Equity Course and , InvestmentBanking Course , which help thousands of candidates land top jobs every year. Fringe benefits can significantly boost job satisfaction, improve employee retention, and attract high-quality candidates.
Behavioral Health, Infusion, and Staffing firms top the list in BRGs survey Many lower middle market private equity groups have revisited their investment priorities as we enter 2025, making room for new opportunities across healthcare verticals. ophthalmology and ENT). However, we expect fewer new platform formations in PPM.
McKessons acquisition of PRISM Vision Group is an important milestone for private equitysinvestments in optometry practices. At the same time, there has always been uncertainty about the ultimate home for these assets, since private equity does not keep its investments forever.
Private equityinvestments in healthcare provider practices are getting more mature and changing the way buyers and sellers approach transactions. Deal activity has been high across dentistry, veterinary, and the physician specialties, with more than 100 private equity backed platforms established and completing their own add-on deals.
Its more of an industry focus at the intersection of several other strategies , such as long/short equity , event-driven investing , and even merger arbitrage. While plenty of bankers and equity research professionals from healthcare teams enter biotech hedge funds, people with advanced degrees (M.D., or Ph.D.),
Consumer retail private equity is so diverse that it almost seems like a paradox. Depending on the firm, a consumer retail private equity deal might consist of: A leveraged buyout of a struggling offline retailer. On the Job Recruiting Should You Go Shopping for Consumer Retail Private Equity Jobs?
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content